PharmaMénta Aps — Credit Rating and Financial Key Figures

PharmaMénta Aps (CVR number: 25615697) is a company from ESBJERG. The company recorded a gross profit of 1939.9 kDKK in 2023. The operating profit was 389.1 kDKK, while net earnings were 6.2 kDKK. The profitability of the company measured by Return on Assets (ROA) was 2.2 %, which can be considered weak and Return on Equity (ROE) was 1 %, which can be considered weak. The equity ratio, a key indicator for solidity, stood at 3.4 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. PharmaMénta Aps's liquidity measured by quick ratio was 0.5 which is at a very low level. Thus, the company is in an unstable financial position, with its liquid assets significantly undermatching its current liabilities. This severe liquidity deficiency may lead to financial distress and threaten the company's operational continuity.